YSL Beauté
This article was originally published in The Rose Sheet
Executive Summary
Pursuing a "measured, opportunistic entry into skin care" is a key goal for YSL going forward, Gucci Group President/CEO Roger Polet reports during a Dec. 14 analyst presentation in London outlining the recently-appointed chief exec's three-year business plan for the company. Division also will focus on recently launched Cinema fragrance and implement a focused media strategy behind Cinema and "key pillar lines," exec adds. Firm will "continue to innovate with creativity and speed," leveraging its size into a competitive advantage, he notes. Company additionally intends to expand YSL beauty products in the U.S. and Japanese markets, which offer "great opportunities for growth," Polet states. The Americas currently comprise 15% of YSL Beauté sales and Japan 5%, while Europe accounts for 67% of revenues. YSL Beauté is expected to generate 3% compound annual sales growth from 2004-2007, according to Polet...
You may also be interested in...
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.